Auf geht's
moneyflow_trader

raising price target to 9.50

Long
Direxion Daily S&P Biotech Bull 3X Shares (AMEX:LABU)  
moneyflow_trader Aktualisiert   
AMEX:LABU   Direxion Daily S&P Biotech Bull 3X Shares
Trend Analysis Harmonic Patterns Chart Patterns
16
0
trendanalysis harmonicpatterns chartpattern
looking for price action to close above D leg of the previous ABCD pattern, and the 3rd Elliot wave. Also looking for these to act as future support levels for any retrace.
Kommentar:
Kommentar:
where I initially saw the 40% move
snapshot
Kommentar:
Kommentar:
c leg has held the retrace in biotech so far
snapshot
Kommentar:
and got long after the short
snapshot
Kommentar:
bull flag breakout on xbi
snapshot
Kommentar:
4hr chart w/ a 1.618 fib level is at 92.09
Kommentar:
Kommentar:
that should put labu at 9.50-10 range
Kommentar:
4hr AD showing an Ascending Triangle
snapshot
Kommentar:
just freaking beautiful
Kommentar:
xbi heading to $92
snapshot
Kommentar:
$160 target for XBI the Biotech ETF, extremely bulish for LABU
AD Ascending Triangle/Bull Flag $160 target
Kommentar:
Monitor this 30min chart of XBI
snapshot
Kommentar:
im monitoring the .618 fib level on the 30min chart potential inverse head and shoulders pattern. Im buyer of all dips
snapshot
Kommentar:
calls locked in 7.50 strike expiration June 30th
snapshot
Kommentar:
Kommentar:
Kommentar:
xbi cup and handle forming on lower time frames
snapshot
Kommentar:
5mi chart of XBI , waiting for the 50 day moving average to cross this spike level, which should then push XBI to $91 area... looking for bullish continuation to the higher time frames as well.
snapshot
Kommentar:
waiting for the key moving avg to cross over the daily spike level on LABU
snapshot
Kommentar:
another good entry point on LABU
snapshot
Kommentar:
would love to add at 84
snapshot
Kommentar:
something im seeing
snapshot
Kommentar:
will buy it back above $7.50 currently short, stop $6.70
snapshot
Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.